Correlation Between Arch Therapeutics and Brainsway

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arch Therapeutics and Brainsway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arch Therapeutics and Brainsway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arch Therapeutics and Brainsway, you can compare the effects of market volatilities on Arch Therapeutics and Brainsway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arch Therapeutics with a short position of Brainsway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arch Therapeutics and Brainsway.

Diversification Opportunities for Arch Therapeutics and Brainsway

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Arch and Brainsway is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Arch Therapeutics and Brainsway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainsway and Arch Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arch Therapeutics are associated (or correlated) with Brainsway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainsway has no effect on the direction of Arch Therapeutics i.e., Arch Therapeutics and Brainsway go up and down completely randomly.

Pair Corralation between Arch Therapeutics and Brainsway

Given the investment horizon of 90 days Arch Therapeutics is expected to under-perform the Brainsway. In addition to that, Arch Therapeutics is 2.99 times more volatile than Brainsway. It trades about -0.11 of its total potential returns per unit of risk. Brainsway is currently generating about 0.0 per unit of volatility. If you would invest  1,000.00  in Brainsway on September 1, 2024 and sell it today you would lose (13.00) from holding Brainsway or give up 1.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Arch Therapeutics  vs.  Brainsway

 Performance 
       Timeline  
Arch Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arch Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Arch Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Brainsway 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Brainsway showed solid returns over the last few months and may actually be approaching a breakup point.

Arch Therapeutics and Brainsway Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arch Therapeutics and Brainsway

The main advantage of trading using opposite Arch Therapeutics and Brainsway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arch Therapeutics position performs unexpectedly, Brainsway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will offset losses from the drop in Brainsway's long position.
The idea behind Arch Therapeutics and Brainsway pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments